Hong Tian, Ph.D.

BeiGene

Hong Tian is Head of Global Statistics at BeiGene, responsible for ensuring adequate statistical support BeiGene’s growing portfolio including clinical development for solid tumor, hematology and non-oncology, quantitative evidence generation post approval and statistics for discovery, biomarker, and manufacturing.  

Hong joined BeiGene in June 2021, following more than 15-year career at Johnson & Johnson Pharmaceutical R&D. Her previous roles include Head of Early Development Statistics for Oncology, Global Clinical Team Statistical Lead for the BCMA CAR-T Program and Functional Manager for Statistical Modeling and Methodology group for Janssen oncology.  Hong has supported various stages of drug development across therapeutic areas has contributed to multiple global marketing authorizations across oncology, cardiovascular and metabolic diseases and infectious diseases areas. Her research interests are multiple comparison, enrichment design and composite endpoint.

Hong obtained her Ph.D. in Biostatistics from Columbia University.